Can a Two-Drug combo wipe out hidden leukemia cells?
Disease control
Not yet recruiting
This phase 2 trial is testing whether combining venetoclax and zanubrutinib can drive chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) into deep remission. The study enrolls adults who either have not been treated before or whose cancer returned at least two…
Phase: PHASE2 • Sponsor: Kerry Rogers • Aim: Disease control
Last updated Jul 31, 2026 00:00 UTC